PEPTIDEGR-3
A triple-receptor research construct engaging GLP-1, GIP, and glucagon pathways in a single lyophilized peptide — built for multi-mechanism metabolic and body-composition research.
Vial size
Qty
Research-grade · ships from Phoenix, AZ · COA on request
- Engages three incretin/metabolic receptors in one construct — GLP-1, GIP, and glucagon.*
- Studied across appetite-signaling and body-composition research models.*
- Lyophilized for shelf stability; reconstitute to precise research doses.*
- Available in 10 / 30 / 60 mg vials for flexible study design.*
- GR-3 triple-agonist peptide
- 10 · 30 · 60 mg / vial
- Bacteriostatic water (BAC)
- 2–3 mL · included
- Needleless mixing device / transfer cap
- 1 included
- 31 G · 5/16″ · 1 mL syringes
- 10 included
For research use only. Not for human or animal consumption.
Why researchers choose it
The GR-3 difference
What sets it apart — framed for research context.
- 01
Engages three incretin/metabolic receptors in one construct — GLP-1, GIP, and glucagon.*
- 02
Studied across appetite-signaling and body-composition research models.*
- 03
Lyophilized for shelf stability; reconstitute to precise research doses.*
- 04
Available in 10 / 30 / 60 mg vials for flexible study design.*
Built on four pillars
Engineered end to end
Active Peptide Complex
A single sequence designed to recruit GLP-1, GIP, and glucagon receptor activity — the three-pathway profile that defines the GR-3 construct.
Delivery & Absorption
Supplied as a lyophilized powder with a BAC water vial and needleless mixing device in the box — reconstitute to exact research concentrations with no needle and no pre-measuring.
Purity & Sourcing
Synthesized to research-grade specification. Identity and purity are documented per lot rather than assumed.
Third-Party Tested
Independent laboratory analysis is kept on file, with a certificate of analysis available for every batch.
Mechanism
One construct. Three receptors.
GLP-1 signaling
Engages the GLP-1 receptor — the incretin pathway most studied for appetite and glucose-handling research.
Composition
What's in the box
GR-3 triple-agonist peptide
Multi-receptor research construct (GLP-1 / GIP / glucagon).
Bacteriostatic water (BAC)
A 2 mL or 3 mL BAC vial, sized to the peptide, ships in the box.
Needleless mixing device / transfer cap
Engineered for Atlas — the vial's vacuum draws the BAC across for instant, needle-free reconstitution (no pre-measuring).
31 G · 5/16″ · 1 mL syringes
Ten individually packaged syringes for research handling.
Head to head
How GR-3 compares
Comparison is illustrative for this demo.
Delivery cadence
Order once, or subscribe.
Choose how often GR-3 ships. Subscriptions can be paused or cancelled anytime.
Subscriptions ship at the full catalog price shown above and can be paused, changed, or cancelled anytime from your account.
Trust & testing
Testing that sets the standard
Identity confirmed
Peptide identity checked per lot before release.
Purity documented
Purity is reported on each certificate of analysis.
Independent lab
Third-party analysis on file — not in-house only.
Questions
Questions? We're here to help.
GR-3 is a single peptide designed to recruit activity at three receptors — GLP-1, GIP, and glucagon — rather than one. This multi-mechanism profile is the focus of current metabolic research interest.
More from this line
Important information
These statements have not been evaluated by the Food and Drug Administration. This product is intended for research use only and is not intended to diagnose, treat, cure, or prevent any disease, nor for human or animal consumption.
- *Research-context statements above are placeholders for demonstration and are pending Arix's review. They are not medical claims.
- *Product-format facts (lyophilized form, vial sizes, reconstitution) describe the research material only.
Claim wording is placeholder — pending Arix approval.














